Graham Capital Management’s Outset Medical OM Stock Holding History

Graham Capital Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-51,070	Closed	-$189K	–	1413
2025 Q4	$189K	Buy	51,070 +36,079	+241%	+$309K	﹤0.01%	1061
2025 Q3	$212K	Buy	+14,991	New	+$234K	﹤0.01%	1028
2023 Q4	–	Sell	-682	Closed	-$111K	–	1232
2023 Q3	$111K	Buy	+682	New	+$161K	﹤0.01%	928
2023 Q2	–	Sell	-2,465	Closed	-$680K	–	1212
2023 Q1	$680K	Buy	2,465 +1,371	+125%	+$503K	0.02%	645
2022 Q4	$424K	Buy	+1,094	New	+$309K	0.01%	800
2022 Q3	–	Sell	-7,795	Closed	-$1.74M	–	1242
2022 Q2	$1.74M	Buy	+7,795	New	+$3.35M	0.07%	248
2022 Q1	–	Sell	-315	Closed	-$217K	–	990
2021 Q4	$217K	Buy	+315	New	+$233K	0.01%	439

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Graham Capital Management's OM Position: Q1 2026 in Review

Graham Capital Management sold out of Outset Medical (OM) in Q1 2026, closing a stake of 51,070 shares — an estimated $189K sold.

Graham Capital Management first reported a position in OM in Q4 2021 and held it in 7 quarters. The position peaked at $1.74M in Q2 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Graham Capital Management reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 51,070 Outset Medical shares in Q1 2026, an estimated $189K.
Graham Capital Management first reported a position in Outset Medical in Q4 2021 and held it in 7 quarters.
Graham Capital Management's Outset Medical position peaked at $1.74M in Q2 2022.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.